Braeburn’s long-acting Brixadi receives FDA clearance to treat opioid use disorder
Braeburn’s long-acting Brixadi receives FDA clearance to treat opioid use disorder Published: May 25, 2023 By Lisa Munger BioSpace Braeburn
Braeburn’s long-acting Brixadi receives FDA clearance to treat opioid use disorder Published: May 25, 2023 By Lisa Munger BioSpace Braeburn
Authors: Corey Hazekamp, MD (@coreyhazekamp, EM Resident Physician, Lincoln Emergency Medicine) and Tony Spadaro, MD (EM Resident Physician,
United States Attorney Zachary Cunha announced on Monday that his office has entered into an agreement with the Donald W. Wyatt Detention Facility
Only a small amount of fentanyl is enough to be lethal. AP Photo/Jacquelyn Martin A medical toxicologist explains by Kavita Babu, UMass Chan
J&J settles West Virginia opioid litigation for $99 mln April 18, 2022, 10:05 AM EDT (Updated 12:00 PM EDT) By Dietrich Knauth (Reuters) –
Walgreens fed opioid addiction, Florida says as trial starts Published April 11, 2022, 11:14 AM EDT By Dietrich Knauth (Reuters) – Walgreens Boots
Apr 08, 2022 By Vanessa Doctor, RN BioSpace Use of classic psychedelics may lower a person’s odds of developing opioid use disorder, said a new
Telehealth may help to engage more patients in addiction treatment by improving access and convenience, but there is limited evidence that patients
Reading Time: 4 minutes Lauren Igneri Critical care pharmacist and proud Rutgers University graduate. Enjoys rock climbing,
The United States has a dearth of physicians who are trained to offer medication treatment with buprenorphine to patients with opioid use disorder
Opioid use disorder (OUD) and overdose among young people who fill an initial opioid prescription are rare but more likely to occur in those who have
1 out of 10 suicides is due to chronic pain, and yet the link between chronic pain and suicide is often ignored. Furthermore, no one connects the
Every Monday our authors provide a round-up of the latest peer-reviewed journal publications. We cover all issues of major health economics journals
Orexo will start a new study of its modia app – used to treat people with opioid use disorder – to test how it performs in real-world
Physicians with a Drug Enforcement Administration (DEA) registration number may no longer be required to apply for a separate waiver to prescribe